A Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health Conditions
Launched by CHIA-HUI HUNG · May 1, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of therapy using extended reality (XR), which includes virtual reality experiences, to see if it can help patients with long-term mental health conditions like schizophrenia. The main focus is on whether this XR therapy can improve patients’ motivation to engage in leisure activities, enhance their emotional coping skills, and boost their overall psychological health. Participants will be divided into two groups: one will use the XR program, which offers engaging virtual activities based on their interests, while the other will continue with typical hospital activities like art or music sessions.
To be eligible for this trial, participants must be adults aged 20 to 65 who have been hospitalized for at least six months and are stable in their mental health condition. They should be able to walk and communicate, and their mental ability should be intact. Over six weeks, those in the XR group will attend weekly sessions lasting 40 minutes. Researchers will gather information through surveys and interviews to understand how the XR therapy affects motivation, coping skills, and overall enjoyment of leisure activities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 20 to 65 years
- • Diagnosed with chronic schizophrenia or schizoaffective disorder (ICD-10 F20.x or F25.x)
- • Hospitalized continuously for at least 6 months
- • Clinically stable with no acute psychiatric symptoms
- • Able to walk independently and communicate verbally
- • Mini-Mental State Examination (MMSE) score ≥ 24
- Exclusion Criteria:
- • History of epilepsy, severe motion sickness, or other seizure-related conditions
- • Significant visual or auditory impairments that may interfere with XR experience
- • Physical conditions that limit participation in leisure activities
- • Current diagnosis of substance abuse or major organic brain disorder
- • Inability to distinguish between reality and virtual environments
About Chia Hui Hung
Chia-Hui Hung is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical standards and regulatory compliance, Chia-Hui Hung collaborates with healthcare professionals and stakeholders to facilitate the development of novel therapies across various therapeutic areas. By leveraging a robust network of resources and expertise, the organization aims to contribute significantly to the scientific community and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported